18-Nov-2019: The global anatomic
pathology market size is expected to reach USD 23.3
billion by 2025, exhibiting a CAGR of 6.1% during the forecast period,
according to a new report by Grand View Research, Inc. The advent of technology
in instruments and protocols used during anatomic pathology is anticipated to
increase the adoption rate of advanced anatomic pathological instruments.
Integration of
medical informatics standards for meeting specific healthcare needs by
enhancing efficiency and curbing costs is a factor driving the market. Market
players are collaborating for refurbishment of pathology laboratories by
incorporating innovative disease diagnostic models. This, in turn, accelerates
investments toward upgradation of pathological equipment.
In April 2018, Thermo
Fisher and Leica Microsystems collaborated for the development of an integrated
cryo-tomography workflow for research. Under this collaboration, the companies
merged their existing technology to deliver enhanced user-friendly and reliable
microscopic solutions, enabling researchers to gain insights about biological
processes.
Pathology-training
programs offered to pathologist trainees by public and private entities drive
the anatomic pathology market. The Royal College of Pathologists, the General
Medical Council, and the Association of Anatomical Pathology Technology are
some organizations that have initiated several training programs and
examinations to evaluate a pathologist’s knowledge and skills.
In
depth research report on Anatomic Pathology Market
Further key findings from the report suggest:
·
Technological advancements in instruments to minimize the
risk of errors through integration of novel design is expected to drive the
segment to register the fastest growth rate
·
High availability, low cost, and frequent purchase rate of
consumables such as reagents and probes have attributed to the dominant revenue
share of consumables
·
Increased implementation of anatomic pathology procedures in
research studies such as tumor examination and biomarker profiling has
propelled the academic research segment
·
Shifting paradigm from conventional medicine to personalized
medicine has resulted in the fastest growth rate of the drug discovery and
development application segment. This is primarily due to growing reliance on
discoveries of putative biomarkers for development of personalized therapies
·
Increase in hospitalization rate that stimulates the adoption
of pathological workflows for disease monitoring and diagnosis has contributed
to the largest share of hospitals
·
On the other hand, growth of the diagnostic laboratories
segment is facilitated by the use of state-of-the-art laboratory equipment and
instrumentation, multiple electronic interfaces, and information systems
·
Presence of key players like Thermo Fisher and Agilent,
coupled with a large number of funding programs by public agencies, contribute
to the largest share of North America
·
Asia Pacific is expected to exhibit the fastest anatomic
pathology market growth driven by the presence of multiple associations that
are engaged in conducting pathology training programs
·
Competitors are adopting strategic initiatives such as
installation of products, agreement, and expansion of distribution channels to
reinforce their market presence. For instance, in July 2018, Thermo Fisher
installed its Krios Cryo-TEM electron microscope at the Institut Pasteur, which
expanded the company’s presence in France.
Grand View Research
has segmented the global anatomic pathology market report on the basis of
product & services, application, end use, and region:
Anatomic Pathology Product & Services Outlook (Revenue,
USD Million, 2014 - 2025)
·
Instruments
·
Microtomes & Cryostat
·
Tissue processors
·
Automatic Stainers
·
Other products
·
Consumables
·
Reagents & Antibodies
·
Probes & Kits
·
Others
·
Services
Anatomic Pathology Application Outlook (Revenue, USD Million,
2014 - 2025)
·
Disease Diagnosis
·
Drug Discovery And Development
·
Others
Anatomic Pathology End-use Outlook (Revenue, USD Million,
2014 - 2025)
·
Hospitals
·
Research Laboratories
·
Diagnostic Laboratories
·
Others
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. is the
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment